Sisram Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.27	70.97	70.23	70.6	81.55	153.06
Short-Term Investments	-	2.07	2.18	0.7	9.95	4.9
Trading Asset Securities	-	-	1.75	-	-	-
Cash & Short-Term Investments	77.27	73.04	74.16	71.3	91.49	157.96
Cash Growth	24.61%	-1.50%	4.01%	-22.07%	-42.08%	32.65%
Accounts Receivable	104.92	92.59	80.76	83.46	80.38	69.88
Other Receivables	-	6.6	3.78	10.8	-	-
Receivables	104.92	99.19	84.54	94.25	80.38	69.88
Inventory	97.3	93.29	81.02	80.55	74.72	64.24
Prepaid Expenses	19.21	3.5	3.02	4.29	-	-
Other Current Assets	0.21	7.28	6.49	6.96	3.97	5.53
Total Current Assets	298.91	276.29	249.21	257.35	250.57	297.6
Property, Plant & Equipment	54.76	56.79	59.47	62.91	52.2	45.46
Long-Term Investments	10.36	10.12	7.92	6.16	16.41	7.17
Goodwill	126.92	126.92	126.92	126.92	111.18	111.18
Other Intangible Assets	133.25	136.7	142.54	136.07	45.29	51.22
Long-Term Accounts Receivable	32.14	35.92	26.55	12.91	13.05	12.55
Long-Term Deferred Tax Assets	11.38	9.95	9.62	9.94	7.25	4.7
Other Long-Term Assets	8.33	4.57	5.03	1.26	59.66	0.25
Total Assets	676.03	657.26	627.26	613.5	555.6	530.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	24.5	22.93	13.36	8	13.34	13.02
Accrued Expenses	-	44.3	43.36	41.13	39.56	39.6
Short-Term Debt	36.11	10.79	4.8	4.42	5.74	7.29
Current Portion of Leases	6.2	5.5	4.41	4.72	2.88	3.09
Current Income Taxes Payable	4.52	4.7	8.88	4.92	1.83	4.06
Current Unearned Revenue	9.17	12.04	15.6	15.9	14.38	15.04
Other Current Liabilities	45.7	6.01	5.09	9.15	2.41	1.45
Total Current Liabilities	126.2	106.25	95.49	88.25	80.13	83.56
Long-Term Leases	36.56	35.46	34	35.54	32.72	31.24
Long-Term Unearned Revenue	4.83	3.46	1.25	0.85	0.59	0.26
Pension & Post-Retirement Benefits	-	1.19	1.32	1.22	1.06	1.72
Long-Term Deferred Tax Liabilities	5.93	7.21	8.67	14.36	8.65	9.41
Other Long-Term Liabilities	1.3	-	1.74	3.76	0.24	0.32
Total Liabilities	174.81	153.58	142.47	143.98	123.38	126.51

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.33	1.33	1.33	1.33	1.33	1.33
Additional Paid-In Capital	-	323.07	323.07	323.07	321.53	319.87
Retained Earnings	-	183.22	171.77	156.33	135.63	104.25
Comprehensive Income & Other	473.46	-27.77	-32.14	-28.42	-27.62	-23.26
Total Common Equity	474.8	479.85	464.03	452.31	430.87	402.18
Minority Interest	26.43	23.83	20.76	17.21	1.35	1.44
Shareholders' Equity	501.23	503.68	484.79	469.53	432.23	403.63
Total Liabilities & Equity	676.03	657.26	627.26	613.5	555.6	530.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	78.87	51.75	43.2	44.68	41.34	41.62
Net Cash (Debt)	-1.6	21.29	30.95	26.62	50.15	116.34
Net Cash Growth	-	-31.23%	16.29%	-46.93%	-56.89%	41.85%
Net Cash Per Share	-0.00	0.05	0.07	0.06	0.11	0.26
Filing Date Shares Outstanding	468.34	468.34	468.34	468.34	467.29	466.16
Total Common Shares Outstanding	468.34	468.34	468.34	468.34	467.29	466.16
Working Capital	172.71	170.04	153.73	169.1	170.44	214.04
Book Value Per Share	1.01	1.02	0.99	0.97	0.92	0.86
Tangible Book Value	214.64	216.24	194.57	189.33	274.4	239.78
Tangible Book Value Per Share	0.46	0.46	0.42	0.40	0.59	0.51
Machinery	-	23.24	21.75	20.42	17.64	13.15
Leasehold Improvements	-	18.72	17.44	16.04	9.9	9.77